Category Archives: SSRI Antidepressants

Featured Stories

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

SSRI Antidepressants Can Increase Patient’s Fear and Anxiety

For some of the millions of people worldwide who take selective serotonin re-uptake inhibitors (SSRIs) to treat depression, the drug may actually increase the patient’s fear and anxiety. This family of widely prescribed drugs includes Prozac (fluoxetine) and Zoloft (sertraline). … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , , , , , , , , , , , , |

Forest Laboratories Denies Claims in Antidepressant Drug Multidistrict Litigation

  Forest Laboratories is facing claims in a multidistrict litigation (MDL) that alleges it misrepresented the efficacy of the antidepressant drugs Lexapro and Celexa for the treatment of depression in pediatric patients. Forest countered telling the Massachusetts federal court that … Continue reading

Posted in Consumer Fraud, Health Concerns, Pharmaceuticals, SSRI Antidepressants |

New Study Warns of Increased Bleeding Risk In Patients with Combined Use of Antidepressants and NSAIDs

Combining Antidepressants & NSAIDs Cause Bleeding Risks

Results of a new study from a research team in Korea indicate that the combined use of antidepressants and nonsteroidal anti-inflammatory drugs (NSAIDs), a common form of painkiller, is associated with an increased risk of intracranial bleeding. The authors write … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants | Tagged , , , , |

Following Husband’s Death, Widow’s Sues Over Allegedly Weak Warning Label on Generic Medication

A widow is suing the maker of  (paroxetine) tablets that her husband, 42 at the time of his death, took as prescribed in 2010. The widow alleges that just six paroxetine tablets led to her husband’s suicide and did not … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressant Use in Pregnancy Tied to Autism Risk

A new study reports that boys with autism were three times more likely to have been exposed to SSRI antidepressants (selective serotonin reuptake inhibitors)  in the womb than typically developing children. Boys whose mothers took SSRIs – including Celexa (citalopram), … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Maternal Use of SSRI Antidepressants Linked to Pulmonary Hypertension in Newborns

ssri-antidepressants-newborn-hypertension

New research shows that maternal use of SSRI antidepressants late in pregnancy is linked to increased risk for persistent pulmonary hypertension (PPH) in newborns. A meta-analysis of seven studies shows a significant association between PPH – increased pressure in the pulmonary arteries – in infants whose … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

Adipotrim XT Dietary Supplement Recalled for Undeclared Drug Ingredient

adipotrim-xt-supplement-recall

Deseo Rebajar Inc., is voluntarily recalling Adipotrim XT, a dietary supplement sold directly to customers in Fajardo, Caguas and Bayamon, Puerto Rico, and online. A U.S. Food and Drug Administration (FDA) laboratory analysis found it to contain undeclared fluoxetine, a selective … Continue reading

Posted in Health Concerns, Pharmaceuticals, Product Recalls, SSRI Antidepressants |

Study: SSRIs Use Tied to Upper GI Bleeds

ssri_tied_to_gi_tract_bleeding

The use of selective serotonin reuptake inhibitors (SSRIs) for as little as seven days presents significant increased risks for upper gastrointestinal (GI) bleeding events, according to a new study. “Consistent with previous studies, SSRIs were the only antidepressants found to … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Certain Antidepressants Linked to Increased Clostridium Difficile Risks

antidepressants-Clostridium-difficile-infections

The antidepressants mirtazapine—sold under the brands Remeron, Avanza, and Zispin—and fluoxetine (known as Prozac, Sarafem, or Fontex) have been associated with an increased risk Clostridium difficile infection (CDI), according to new research. Investigators at the University of Michigan in Ann … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

JAMA Study: Perioperative SSRI Use Associated with Increased Adverse Event Risks

SSRI-Adverse_Effects

A new study found that patients taking selective serotonin reuptake inhibitors (SSRIs) during the perioperative period (from hospitalization admission to discharge) were at increased risks for suffering an adverse event. The study appears in the April 29, 2013 issue of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.